Lu Jessica K, Law Yin Jun, Zhang Ning, Katsika Evangelia T, Kolibianakis Efstratios M, Venetis Christos A
School of Women's and Children's Health, UNSW Medicine and Health, University of New South Wales, Sydney, Randwick, Australia.
Unit for Human Reproduction, 1st Department of Obstetrics and Gynaecology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece.
Hum Reprod Open. 2025 Jun 18;2025(3):hoaf033. doi: 10.1093/hropen/hoaf033. eCollection 2025.
How is recurrent implantation failure (RIF) defined in published literature and what is the prognostic agreement of these definitions with recently introduced RIF criteria by ESHRE?
RIF definitions used in current clinical studies are highly variable and only a low proportion of published studies on RIF meet the ESHRE RIF diagnostic threshold.
RIF is a key cause of ART failure and growing focus of ART research. However, RIF remains poorly and inconsistently defined in published literature, thereby making the interpretation and clinical applicability of RIF research difficult and highly problematic.
The electronic databases EMBASE (Ovid), PubMed, Cochrane Central Register Of Controlled Trials (CENTRAL), Scopus, and Web of Science were systematically searched up to 30 June 2024 using the search terms 'recurrent implantation failure' and 'repeated implantation failure' for original peer-reviewed journal articles that included RIF patients.
PARTICIPANTS/MATERIALS SETTING METHODS: The following data were manually extracted from eligible full-text articles: study methodology and characteristics, ART characteristics, and the RIF definition used. Extracted RIF definitions were analysed according to predetermined specifiers. The prognostic profile of these RIF definitions was compared with the 2023 ESHRE-recommended threshold for RIF diagnosis.
The literature search identified 9853 studies, of which 748 were eligible for inclusion. Of these 748 studies, 589 studies (78.7%) provided one RIF definition, 83 studies (11.1%) used two definitions, three studies (0.4%) provided three or more definitions while 73 studies (9.8%) did not provide a definition for RIF. Of the 838 RIF definitions retrieved, there were a total of 503 unique RIF definitions. The three most common specifiers used to define RIF were embryo morphological quality (n = 491, 58.6% of RIF definitions), number of transfer events (n = 439, 52.4%), and cumulative number of embryos transferred (n = 326, 38.9%). RIF was most frequently diagnosed as 'failure of ≥3 embryo transfer events' (n = 26) and 'failure of ≥3 stimulated cycles' (n = 22). The threshold for defining RIF based on the cumulative number of embryos transferred in total was significantly higher for cleavage-stage embryos compared to blastocysts (incidence rate ratio 2.15, < 0.001). In most cases, the RIF definitions used did not meet the ESHRE-recommended RIF diagnostic threshold of >60% cumulative predicted chance of implantation.
This systematic review excluded abstracts and case-series. Several studies provided RIF definitions with limited detail or ambiguous terminology with potential for misclassification or misinterpretation.
There remains a high degree of variability and discrepancy between RIF definitions used in current clinical studies on RIF. Furthermore, the low proportion of studies meeting the ESHRE RIF diagnostic threshold casts doubts on whether the populations in these studies were truly RIF patients. As such, published research findings should be interpreted with caution. To enable wider clinical applicability of future research on the aetiology of and therapeutic interventions for RIF, it is imperative that a standardized RIF definition is meticulously implemented.
STUDY FUNDING/COMPETING INTERESTS: No specific external funding was sought or obtained for this study. All authors report no conflicts of interest with regard to this study.
This trial was registered in PROSPERO (CRD42022295349).
已发表文献中如何定义反复种植失败(RIF),这些定义与欧洲人类生殖与胚胎学会(ESHRE)最近提出的RIF标准的预后一致性如何?
当前临床研究中使用的RIF定义高度可变,关于RIF的已发表研究中只有一小部分符合ESHRE的RIF诊断阈值。
RIF是辅助生殖技术(ART)失败的关键原因,也是ART研究日益关注的焦点。然而,RIF在已发表文献中的定义仍然不明确且不一致,从而使得RIF研究的解释和临床适用性变得困难且问题重重。
研究设计、规模、持续时间:截至2024年6月30日,对电子数据库EMBASE(Ovid)、PubMed、Cochrane对照试验中心注册库(CENTRAL)、Scopus和科学网进行了系统检索,使用检索词“反复种植失败”和“重复种植失败”查找纳入了RIF患者的原始同行评审期刊文章。
参与者/材料、设置、方法:从符合条件的全文文章中手动提取以下数据:研究方法和特征、ART特征以及使用的RIF定义。根据预先确定的说明符对提取的RIF定义进行分析。将这些RIF定义的预后情况与2023年ESHRE推荐的RIF诊断阈值进行比较。
文献检索共识别出9853项研究,其中748项符合纳入标准。在这748项研究中,589项研究(78.7%)提供了一个RIF定义,83项研究(11.1%)使用了两个定义,3项研究(0.4%)提供了三个或更多定义,而73项研究(9.8%)未提供RIF定义。在检索到的838个RIF定义中,共有503个独特的RIF定义。用于定义RIF的三个最常见说明符是胚胎形态质量(n = 491,占RIF定义的58.6%)、移植次数(n = 439,52.4%)和累计移植胚胎数(n = 326,38.9%)。RIF最常被诊断为“≥3次胚胎移植失败”(n = 26)和“≥3个促排卵周期失败”(n = 22)。与囊胚相比,基于总移植胚胎数定义RIF的阈值在卵裂期胚胎中明显更高(发病率比2.15,P < 0.001)。在大多数情况下,所使用的RIF定义未达到ESHRE推荐的RIF诊断阈值,即累计植入预测概率>60%。
局限性、谨慎的原因:本系统评价排除了摘要和病例系列。几项研究提供的RIF定义细节有限或术语模糊,存在分类错误或误解的可能性。
当前关于RIF的临床研究中使用的RIF定义之间仍存在高度的变异性和差异。此外,符合ESHRE RIF诊断阈值的研究比例较低,令人怀疑这些研究中的人群是否真的是RIF患者。因此,对已发表的研究结果应谨慎解释。为了使未来关于RIF病因和治疗干预的研究具有更广泛的临床适用性,必须精心实施标准化的RIF定义。
研究资金/利益冲突:本研究未寻求或获得特定的外部资金。所有作者均报告在本研究中无利益冲突。
本试验在国际前瞻性系统评价注册库(PROSPERO)注册(CRD42022295349)。